| Pre-treatment (n = 10) | Clin range | Post-treatment (n = 10) | Clin range | Clin M | ||
---|---|---|---|---|---|---|---|
M | SD | M | SD | ||||
Parents | |||||||
CPQ | 27.73 | 5.68 | n/a | 26.80 | 5.03 | n/a | 28.53(1) |
EDE-Q | 1.43 | 0.85 | Sub-clinical | 1.54 | 0.83 | Sub-clinical | 3.98(2) |
PHQ-9 | 15.82 | 6.72 | Moderate | 13.80 | 5.47 | Mild | 15.5(3) |
GAD-7 | 12.55 | 3.30 | Moderate | 11.30 | 5.23 | Moderate | 14.1(4) |
Adolescents | |||||||
CPQ | 28.82 | 5.71 | n/a | 28.00 | 5.94 | n/a | 26.17(5) |
EDE-Q | 3.14 | 0.79 | Clinical | 2.98 | 1.14 | Sub-clinical | 3.98(2) |
PHQ-9 | 19.73 | 5.87 | Moderate | 17.20 | 6.11 | Moderate | 15.5(3) |
GAD-7 | 15.27 | 4.69 | Severe | 14.50 | 3.84 | Moderate | 14.1(4) |